Since 1991, Ravimed has been manufacturing containers for blood collection, storage and processing with solutions for blood preservation for therapeutic purposes, which constitute a closed system for the optimum use of blood and its components.

Sets of containers for blood collection, storage and processing with solution for blood preservation are intended, depending on their configuration, for the following:

• single
• full blood collection and storage;
• double
• full blood division into two parts
• separation of red blood cells from plasma
• triple
• full blood division into three parts
• blood division into red blood cells, platelets and plasma
• quadruple
• full blood division into four parts
• blood division into red blood cells, leukocytes, platelets and plasma;
• fivefold
• full blood division into four parts
• blood division into red blood cells, leukocytes, platelets and plasma;
• six fold
• full blood division into four parts
• blood division into red blood cells, leukocytes, platelets and plasma;
• double plasmapharesis
• to acquire plasma through the separation of red blood cells from plasma and return them to the donor.

Blood fixatives (anticoagulants) and blood enriching liquids may contain Citric acid, sodium citrate, sodium phosphate, glucose, adenin, sodium citrate and mannitol:

• ACD-A – Acid citric, Citrate, Dextrose (glucose);
• CPDA-1 – Citrate, Phosphate, Dextrose, Adenine,
• CPD – Citrate, Phosphate, Dextrose,
• SAGM – Saline (Sodium chloride), Adenine, Glucose, Mannitol;

and ensure anticoagulation of the full blood and its storage for:

• CPD – 21 days
• CPDA-1 – 35 days
• SAGM – 42 days

Optionally, depending on their intended use, sets of containers are equipped with the following:

• casing which enables the protection of the needle after blood collection (protector)
• adapter which enables the collection of blood samples (undiluted with the fixative) during donation
• empty (transfer) container with a steel or plastic needle („Spike”)
• filter for leukocyte reduction type 402 erythrocyte reduction type 502